{"id":44646,"date":"2022-06-03T02:01:17","date_gmt":"2022-06-03T00:01:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/"},"modified":"2022-06-03T02:01:17","modified_gmt":"2022-06-03T00:01:17","slug":"lysulin-announces-lifting-of-fda-ftc-warning-letter","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/","title":{"rendered":"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements.\n<\/p>\n

\nDr. John F. Burd, Ph.D., CEO of Lysulin, said, \u201cLysulin is pleased to report that we have resolved the issues raised by the FDA and the FTC relating to the promotion and advertising of our dietary supplements. We held productive conversations with the FDA regarding our product claims, and we remain committed to bringing consumers a first-in-class nutritional supplement formulated to assist with glucose management in a responsible and transparent manner.\u201d\n<\/p>\n

\nLysulin provides a clinically studied approach for goal-oriented blood glucose management, available in over-the-counter dietary supplements.* Lysulin\u2019s unique, patented formulation contains three carefully balanced essential nutrients: Lysine, Zinc and Vitamin C, which in over 20 years of independent research have been shown to help consumers maintain healthy blood glucose levels.*\n<\/p>\n

\nGlucose in the blood attaches to proteins in the body, changing the protein\u2019s structure and affecting how these proteins function. This destructive process is called protein glycation, which many experts believe is the main cause of unhealthy blood sugar levels and insulin resistance. Hemoglobin A1c (A1c) is a glycated protein, and because A1c levels measure the average blood glucose over the prior three months, physicians use the A1c test to measure blood glucose levels. Maintaining healthy A1c levels significantly reduces the risk of blood sugar complications.\n<\/p>\n

\n\u201cLysulin is delivering remarkable results in nutritional support for people who want to maintain healthy glucose levels,\u201d said Burd. \u201cLysulin is committed to delivering its innovative formulation, backed by science, to help support a proactive approach to a healthy lifestyle. Nutrition and daily exercise are also critical components to maintaining healthy blood sugar levels.\u201d\n<\/p>\n

\nWith over 30 years of experience in glucose monitoring technology, Dr. Burd was founder and CEO of Dexcom and is renowned for his work in the medical and biotechnology field. He was inducted into the American Association of Clinical Chemistry (AACC) Hall of Fame in 2005 after winning the Ullman prize for innovation in clinical chemistry.\n<\/p>\n

\nLysulin\u2019s supplements are easy-to-take, gluten free, vegetarian and vegan. Lysulin is available without a prescription and can be purchased at www.lysulin.com<\/a>. For accompanying information for this press release and for further details about Lysulin, visit Lysulin.com.\n<\/p>\n

\n*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJohn Burd, PhD
\n
Email: jburd@jfburd.com<\/a>
Phone: 619-992-2873\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements. Dr. John F. Burd, Ph.D., CEO of Lysulin, said, \u201cLysulin is pleased to report that we have resolved the issues raised by … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44646","6":"format-standard","7":"category-industry"},"yoast_head":"\nLysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements. Dr. John F. Burd, Ph.D., CEO of Lysulin, said, \u201cLysulin is pleased to report that we have resolved the issues raised by ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-03T00:01:17+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lysulin\u00ae Announces Lifting of FDA\\\/FTC Warning Letter\",\"datePublished\":\"2022-06-03T00:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/\"},\"wordCount\":440,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/\",\"name\":\"Lysulin\u00ae Announces Lifting of FDA\\\/FTC Warning Letter - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-06-03T00:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lysulin-announces-lifting-of-fda-ftc-warning-letter\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lysulin\u00ae Announces Lifting of FDA\\\/FTC Warning Letter\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/","og_locale":"en_US","og_type":"article","og_title":"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–Lysulin, Inc. announced today that is has received a close-out letter from the U.S. Food and Drug Administration lifting a 2021 warning letter relating to its promotion of Lysulin dietary supplements. Dr. John F. Burd, Ph.D., CEO of Lysulin, said, \u201cLysulin is pleased to report that we have resolved the issues raised by ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-03T00:01:17+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter","datePublished":"2022-06-03T00:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/"},"wordCount":440,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/","url":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/","name":"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-06-03T00:01:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lysulin-announces-lifting-of-fda-ftc-warning-letter\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lysulin\u00ae Announces Lifting of FDA\/FTC Warning Letter"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44646"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44646\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}